Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Aglaia Oncology Funds

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 10
Average round size
info
The average size of a deal this fund participated in
$14M
Portfolio companies 7
Rounds per year 0.56
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.30
Exits 1
Key employees 4

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Therapeutics
  • Information Technology
  • Health Care

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Ashoka India Equity Investment Trust -
ClearVision Equity Partners California, San Diego, United States
Community Development Financial Institutions Fund (CDFI Fund) -
Cuneo & Co. -
Foxconn T'ai-wan, Taitung County, Taiwan
Gadsden Investments -
Metis Investments -
NMA Ventures Albuquerque, New Mexico, United States
Point Field Partners -
Profile Capital -
Rongming Capital Management Beijing, Beijing, China
Sempra Energy California, San Diego, United States
SherpaShare California, Menlo Park, United States
SmartCap Estonia, Harjumaa, Tallinn
Sonovate England, London, United Kingdom
Votum Capital Jackson, Mississippi, United States
YI Technology California, Sunnyvale, United States
Zhuhai Yuansheng Ziben Guanli China, Guangdong, Zhuhai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Sapreme Technologies

Biotechnology
Life Science
Pharmaceutical
$17M07 Oct 2021 Bilthoven, Utrecht, The Netherlands

InteRNA Technologies

Biotechnology
Information Technology
Therapeutics
$21M09 Feb 2021 New Haven, Connecticut, United States

Inthera Bioscience

Biotechnology
Pharmaceutical
$5M26 Jun 2018 Zurich, Switzerland

Mimetas

3D Technology
Biotechnology
Health Care
Information Technology
$20M11 Apr 2018 South Holland

Inthera Bioscience

Biotechnology
Pharmaceutical
$11M31 May 2017 Zurich, Switzerland

Macrophage Pharma

Biotechnology
Pharmaceutical
Therapeutics
$12M09 Jan 2017 Ohio, United States

InteRNA Technologies

Biotechnology
Information Technology
Therapeutics
$10M15 Dec 2015 New Haven, Connecticut, United States

Inthera Bioscience

Biotechnology
Pharmaceutical
$4M14 Dec 2015 Zurich, Switzerland

Merus

Biotechnology
Health Care
Medical
Therapeutics
$25M29 Jan 2010 Utrecht, Utrecht, Netherlands

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Aglaia Oncology Funds?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 10
Average round size 14M
Rounds per year 0.56
Peak activity year 2017
Lead investments 3
Follow on index 0.30
Exits 1
Group Appearance index 0.90

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Sapreme Technologies

Biotechnology
Life Science
Pharmaceutical
$17M07 Oct 2021 Bilthoven, Utrecht, The Netherlands

InteRNA Technologies

Biotechnology
Information Technology
Therapeutics
$21M09 Feb 2021 New Haven, Connecticut, United States

Inthera Bioscience

Biotechnology
Pharmaceutical
$5M26 Jun 2018 Zurich, Switzerland

Mimetas

3D Technology
Biotechnology
Health Care
Information Technology
$20M11 Apr 2018 South Holland

Inthera Bioscience

Biotechnology
Pharmaceutical
$11M31 May 2017 Zurich, Switzerland

Macrophage Pharma

Biotechnology
Pharmaceutical
Therapeutics
$12M09 Jan 2017 Ohio, United States

InteRNA Technologies

Biotechnology
Information Technology
Therapeutics
$10M15 Dec 2015 New Haven, Connecticut, United States

Inthera Bioscience

Biotechnology
Pharmaceutical
$4M14 Dec 2015 Zurich, Switzerland

Merus

Biotechnology
Health Care
Medical
Therapeutics
$25M29 Jan 2010 Utrecht, Utrecht, Netherlands
Crunchbase icon

Content report

The following text will be sent to our editors: